Teleflex Pilling Wecksorb Cylindrical Sponges Recall: Sterility Risk
Teleflex recalls specific lots of Pilling Wecksorb Cylindrical Sponges due to potential sterility issues from unirradiated products. Affected items may not be sterile, posing infection risks.
Lower-risk recall
Specific lots have not been irradiated to eliminate pyronema and therefore the sterility of the affected products may be compromised.
Contact the company
What happened, in plain English
Teleflex is recalling specific lots of Pilling Wecksorb C:ylindrical Sponges because they weren't properly irradiated to ensure sterility. Using these sponges could lead to infections if they're not sterile. Read more at govinfonow.com/recall/59993-teleflex-pilling-wecksorb-cylindrical-sponges-recall-sterility-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/59993-teleflex-pilling-wecksorb-cylindrical-sponges-recall-sterility-risk · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0772-2023
Cite this page
“Teleflex Pilling Wecksorb Cylindrical Sponges Recall: Sterility Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/59993-teleflex-pilling-wecksorb-cylindrical-sponges-recall-sterility-risk. Based on FDA recall #Z-0772-2023 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0772-2023%22&limit=1).
Why it’s dangerous
The sponges weren't irradiated to eliminate pyronema, which can compromise sterility. If the sponges aren't sterile, they could cause infections during medical procedures.
Who’s affected
Users of the recalled sponges, particularly those in medical settings where sterility is critical. Patients undergoing procedures using these sponges are at higher risk.
How to tell if you have this one
Check for Catalog Number 200400 and Lot Number 22B0395 on the product packaging. These specific lots were affected by the recall.
- Brand
Teleflex- Category
Medical device
What to do — step by step
Check Product Details
Look for Catalog Number 200400 and Lot Number 22B0395 on the sponge packaging to confirm if it's affected.
Where it went and when
Where it was distributed
Distributed in 4 states.
FDA distribution: “Domestic distribution to IL, MS, PA, TN.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Illinois, Mississippi, Pennsylvania, Tennessee.
Recall timeline
FDA terminated this recall 3.8 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-0772-2023 (September 28, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0772-2023 to see it in context.
- Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.